These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35045168)

  • 21. Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus.
    Salvadori N; Fan B; Teeyasoontranon W; Ngo-Giang-Huong N; Phanomcheong S; Luvira A; Puangsombat A; Suwannarat A; Srirompotong U; Putiyanun C; Cressey TR; Decker L; Khamduang W; Harrison L; Tierney C; Shepherd JA; Kourtis AP; Bulterys M; Siberry GK; Jourdain G
    Clin Infect Dis; 2019 Jun; 69(1):144-146. PubMed ID: 30924492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region.
    Samadi Kochaksaraei G; Castillo E; Osman M; Simmonds K; Scott AN; Oshiomogho JI; Lee SS; Myers RP; Martin SR; Coffin CS
    J Viral Hepat; 2016 Jan; 23(1):15-22. PubMed ID: 26192022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Administration of Tenofovir Disoproxil Fumarate for Pregnant Japanese Women with Chronic Hepatitis B.
    Suoh M; Tamori A; Amano-Teranishi Y; Nakai T; Enomoto M; Kawasaki Y; Kioka K; Kawada N
    Intern Med; 2020; 59(2):205-210. PubMed ID: 31941870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.
    Buti M; Gane E; Seto WK; Chan HL; Chuang WL; Stepanova T; Hui AJ; Lim YS; Mehta R; Janssen HL; Acharya SK; Flaherty JF; Massetto B; Cathcart AL; Kim K; Gaggar A; Subramanian GM; McHutchison JG; Pan CQ; Brunetto M; Izumi N; Marcellin P;
    Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):196-206. PubMed ID: 28404092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV.
    Wang J; Liu J; Qi C; Yan T; Cao F; Jin L; He Y; Yang Y; Zhang S; Chen T; Zhao Y
    Antivir Ther; 2015; 20(7):681-7. PubMed ID: 26215771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
    [No Abstract]   [Full Text] [Related]  

  • 27. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.
    Chan HL; Fung S; Seto WK; Chuang WL; Chen CY; Kim HJ; Hui AJ; Janssen HL; Chowdhury A; Tsang TY; Mehta R; Gane E; Flaherty JF; Massetto B; Gaggar A; Kitrinos KM; Lin L; Subramanian GM; McHutchison JG; Lim YS; Acharya SK; Agarwal K;
    Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):185-195. PubMed ID: 28404091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women.
    Mugwanya K; Baeten J; Celum C; Donnell D; Nickolas T; Mugo N; Branch A; Tappero J; Kiarie J; Ronald A; Yin M; Wyatt C;
    J Infect Dis; 2016 Oct; 214(7):1050-7. PubMed ID: 27029778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus.
    Chen HL; Lee CN; Chang CH; Ni YH; Shyu MK; Chen SM; Hu JJ; Lin HH; Zhao LL; Mu SC; Lai MW; Lee CL; Lin HM; Tsai MS; Hsu JJ; Chen DS; Chan KA; Chang MH; ;
    Hepatology; 2015 Aug; 62(2):375-86. PubMed ID: 25851052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study.
    Li Z; Xie B; Yi N; Cai H; Yi W; Gao X
    Eur J Obstet Gynecol Reprod Biol; 2022 Sep; 276():102-106. PubMed ID: 35853269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tenofovir disoproxil fumarate for prevention of mother-to-child transmission of hepatitis B virus: A systematic review and meta-analysis of randomised control trials.
    Zeleke ED; Assefa DG; Joseph M; Bekele D; Tesfahunei HA; Getachew E; Manyazewal T
    Rev Med Virol; 2021 Sep; 31(5):1-16. PubMed ID: 33483986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV.
    Pan CQ; Chang TT; Bae SH; Brunetto M; Seto WK; Coffin CS; Tan SK; Mo S; Flaherty JF; Gaggar A; Nguyen MH; Çelen MK; Thompson A; Gane EJ
    PLoS One; 2021; 16(5):e0251552. PubMed ID: 33984038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate-treated chronic hepatitis B pregnant patients in North America.
    Samadi Kochaksaraei G; Castillo E; Sadler MD; Seow CH; Barkema HW; Martin SR; Israelson H; Pinto J; Williams S; Aspinall AI; Stinton LM; Borman MA; Burak KW; Swain MG; Congly SE; Lee SS; Shaheen AA; Coffin CS
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1707-1716. PubMed ID: 33111382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.
    Mokaya J; Burn EAO; Tamandjou CR; Goedhals D; Barnes EJ; Andersson M; Pinedo-Villanueva R; Matthews PC
    BMC Public Health; 2019 Jun; 19(1):829. PubMed ID: 31242901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of different antiviral regimens on the viral loads in pregnant women with hepatitis B virus infection and their impact on mother-to-child transmission.
    Xu B; Liu L; Chen X
    J Obstet Gynaecol Res; 2021 Jun; 47(6):2110-2116. PubMed ID: 33765690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load.
    Wang M; Bian Q; Zhu Y; Pang Q; Chang L; Li R; Tiongson BC; Zhang H; Pan CQ
    Aliment Pharmacol Ther; 2019 Jan; 49(2):211-217. PubMed ID: 30506691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: A meta-analysis.
    Song J; Yang F; Wang S; Tikande S; Deng Y; Tang W; Cao G
    J Viral Hepat; 2019 Mar; 26(3):397-406. PubMed ID: 30417469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus.
    Cressey TR; Harrison L; Achalapong J; Kanjanavikai P; Patamasingh Na Ayudhaya O; Liampongsabuddhi P; Siriwachirachai T; Putiyanun C; Suriyachai P; Tierney C; Salvadori N; Chinwong D; Decker L; Tawon Y; Murphy TV; Ngo-Giang-Huong N; Siberry GK; Jourdain G;
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low levels of tenofovir in breast milk support breastfeeding in HBV-infected mothers treated with tenofovir disoproxil fumarate.
    Li S; Jin J; Jiang Y; Shi J; Jiang X; Lin N; Ma Z
    Int J Antimicrob Agents; 2023 Mar; 61(3):106726. PubMed ID: 36646229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study.
    Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Chen ZM; Cui GL; Li W; Zhang DW; Li J; Lv J; Li ZQ; Liang HX; Sun CY; Pan YJ; Liu YM; Wang FS
    Clin Infect Dis; 2021 Nov; 73(9):e3324-e3332. PubMed ID: 33395488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.